Fig. 4From: Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolismRegulatory effects of M3BIM on PLCγ2 and PKC activation in platelets. Washed platelets were preincubated with 25 or 50 μM M3BIM or a solvent control (0.5 % DMSO) and subsequently treated with 1 μg/mL of collagen or 150 nM PDBu to induce either PLCγ2 a or PKC activation (p47 phosphorylation) b and c and platelet aggregation d. Data are presented as the means ± SEM (n = 4). ** P < 0.01 and *** P < 0.001, compared with the resting platelets; # P < 0.05 and ## P < 0.01, compared with the platelets receiving the solvent control. Profiles d are representative of four independent experimentsBack to article page